Safar ME - Search Results

1

Central hemodynamics in risk assessment strategies: additive value over and above brachial blood pressure.

Yannoutsos A, Rinaldi ER, Zhang Y, Protogerou AD, Safar ME, Blacher J. Yannoutsos A, et al. Among authors: safar me. Curr Pharm Des. 2015;21(6):719-29. doi: 10.2174/1381612820666141023164125. Curr Pharm Des. 2015. PMID: 25341861 Review.

2

Large artery stiffness and antihypertensive agents.

Blacher J, Protogerou AD, Safar ME. Blacher J, et al. Among authors: safar me. Curr Pharm Des. 2005;11(25):3317-26. doi: 10.2174/138161205774424654. Curr Pharm Des. 2005. PMID: 16250848 Review.

3

Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification.

Safar ME, Blacher J, Protogerou A, Achimastos A. Safar ME, et al. J Hypertens. 2008 Jan;26(1):130-7. doi: 10.1097/HJH.0b013e3282f16a9c. J Hypertens. 2008. PMID: 18090550

4

Is there any additional prognostic value of central blood pressure wave forms beyond peripheral blood pressure?

Sabovic M, Safar ME, Blacher J. Sabovic M, et al. Among authors: safar me. Curr Pharm Des. 2009;15(3):254-66. doi: 10.2174/138161209787354249. Curr Pharm Des. 2009. PMID: 19149615 Review.

5

The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part I: (Patho)-physiology, rationale and perspective on pulse pressure amplification.

Protogerou AD, Papaioannou TG, Lekakis JP, Blacher J, Safar ME. Protogerou AD, et al. Among authors: safar me. Curr Pharm Des. 2009;15(3):267-71. doi: 10.2174/138161209787354267. Curr Pharm Des. 2009. PMID: 19149617 Review.

6

Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation.

Agnoletti D, Zhang Y, Borghi C, Blacher J, Safar ME. Agnoletti D, et al. Among authors: safar me. Am J Hypertens. 2013 Aug;26(8):1045-52. doi: 10.1093/ajh/hpt081. Epub 2013 Jun 4. Am J Hypertens. 2013. PMID: 23736112 Clinical Trial.

7

Central hemodynamics for risk reduction strategies: additive value over and above brachial blood pressure.

Rinaldi ER, Yannoutsos A, Borghi C, Safar ME, Blacher J. Rinaldi ER, et al. Among authors: safar me. Curr Pharm Des. 2015;21(6):730-6. doi: 10.2174/1381612820666141023164530. Curr Pharm Des. 2015. PMID: 25341860 Review.

8

Optimal blood pressure target in stroke prevention.

Yannoutsos A, Dreyfuss Tubiana C, Safar ME, Blacher J. Yannoutsos A, et al. Among authors: safar me. Curr Opin Neurol. 2017 Feb;30(1):8-14. doi: 10.1097/WCO.0000000000000407. Curr Opin Neurol. 2017. PMID: 27906755 Review.

9

Should blood pressure goal be individualized in hypertensive patients?

Yannoutsos A, Kheder-Elfekih R, Halimi JM, Safar ME, Blacher J. Yannoutsos A, et al. Among authors: safar me. Pharmacol Res. 2017 Apr;118:53-63. doi: 10.1016/j.phrs.2016.11.037. Epub 2016 Dec 2. Pharmacol Res. 2017. PMID: 27919826 Review.

10

Heart rate and pulse pressure amplification in hypertensive subjects.

Laurent P, Albaladejo P, Blacher J, Rudnichi A, Smulyan H, Safar ME. Laurent P, et al. Among authors: safar me. Am J Hypertens. 2003 May;16(5 Pt 1):363-70. doi: 10.1016/s0895-7061(03)00063-3. Am J Hypertens. 2003. PMID: 12745197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

675 results

Search Page

Filters